Duosulin 30:70 Suspension for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

duosulin 30:70 suspension for injection (im/sc)

pnf pharmaceutical, inc.; distributor: duopharma trade phils., inc. - insulin human (dna) - suspension for injection (im/sc) - 100 iu/ml (30% soluble insulin human / 70% isophane insulin human)

Inpremzia European Union - English - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - diabetes mellitus - drugs used in diabetes - inpremzia is indicated for the treatment of diabetes mellitus.

Insuljack 30:70 100 IU/mL Philippines - English - FDA (Food And Drug Administration)

insuljack 30:70 100 iu/ml

n/a; importer: pnf pharmaceutical, inc.; distributor: jackpharma inc. - insulin human (rdna) - suspension for injection (im/sc) (30% soluble insulin human/ 70% isophane insulin human) - 100 iu/ml

ProZinc European Union - English - EMA (European Medicines Agency)

prozinc

boehringer ingelheim vetmedica gmbh - insulin human - insulins and analogues for injection, intermediate-acting - cats; dogs - for the treatment of diabetes mellitus in cats and dogs to achieve reduction of hyperglycaemia and improvement of associated clinical signs.

Humulin 30/70 New Zealand - English - Medsafe (Medicines Safety Authority)

humulin 30/70

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Humulin NPH New Zealand - English - Medsafe (Medicines Safety Authority)

humulin nph

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Humulin R New Zealand - English - Medsafe (Medicines Safety Authority)

humulin r

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: glycerol hydrochloric acid as 10% solution for ph adjustment metacresol sodium hydroxide as 10% solution for ph adjustment water for injection - humulin is indicated for the treatment of insulin-requiring diabetes mellitus.